Berman Capital Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$10,000
-23.1%
249
-13.2%
0.00%0.0%
Q2 2021$13,000
+44.4%
287
+31.7%
0.00%0.0%
Q1 2021$9,000
+12.5%
218
+3.8%
0.00%0.0%
Q4 2020$8,000
+60.0%
210
+4.0%
0.00%
+100.0%
Q3 2020$5,0000.0%2020.0%0.00%0.0%
Q2 2020$5,0002020.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders